|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| PRDO | Hurst Andrew | President & CEO | Aug 21 '23 | Option Exercise | 5.45 | 15,000 | 81,750 | 367,641 | Aug 22 04:15 PM |
| PRDO | Hurst Andrew | President & CEO | Aug 22 '23 | Option Exercise | 5.72 | 1,510 | 8,634 | 354,151 | Aug 22 04:15 PM |
| PRDO | Hurst Andrew | President & CEO | Aug 22 '23 | Sale | 16.11 | 1,510 | 24,326 | 352,641 | Aug 22 04:15 PM |
| PRDO | Hurst Andrew | President & CEO | Aug 21 '23 | Sale | 15.98 | 15,000 | 239,700 | 352,641 | Aug 22 04:15 PM |
| PRDO | Hurst Andrew | President & CEO | Aug 17 '23 | Option Exercise | 5.45 | 15,000 | 81,750 | 367,641 | Aug 21 04:15 PM |
| PRDO | Hurst Andrew | President & CEO | Aug 18 '23 | Option Exercise | 5.45 | 15,000 | 81,750 | 367,641 | Aug 21 04:15 PM |
| PRDO | Hurst Andrew | President & CEO | Aug 18 '23 | Sale | 16.02 | 15,000 | 240,300 | 352,641 | Aug 21 04:15 PM |
| PRDO | Hurst Andrew | President & CEO | Aug 17 '23 | Sale | 16.12 | 15,000 | 241,800 | 352,641 | Aug 21 04:15 PM |
| PRDO | Hurst Andrew | SVP, CTU | May 13 '21 | Sale | 11.94 | 9,940 | 118,684 | 218,352 | May 14 04:25 PM |
| CECO | Hurst Andrew | SVP, CTU | Sep 16 '19 | Sale | 19.18 | 14,388 | 275,962 | 187,853 | Sep 18 01:11 PM |
| CECO | Hurst Andrew | SVP, CTU | Sep 17 '19 | Sale | 18.97 | 13,654 | 259,016 | 174,199 | Sep 18 01:11 PM |
| CECO | Hurst Andrew | SVP, CTU | Dec 03 '18 | Sale | 14.00 | 16,531 | 231,434 | 100,931 | Dec 06 08:44 AM |
| CECO | Hurst Andrew | SVP, CTU | Nov 02 '18 | Sale | 14.32 | 1,300 | 18,616 | 117,462 | Nov 05 04:36 PM |
| CECO | Hurst Andrew | SVP, CTU | Nov 17 '17 | Sale | 12.81 | 3,889 | 49,820 | 102,997 | Nov 20 05:01 PM |
| CECO | Hurst Andrew | SVP, CTU | Nov 21 '16 | Sale | 9.72 | 6,592 | 64,105 | 101,010 | Nov 22 12:20 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite